SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
24h
Current
Min
113.25
Max
117
Income | -142M 667M |
---|---|
Sales | 152M 5.4B |
P/E Sector Avg | 26.27 56.602 |
EPS | 2.2 |
Dividend yield | 1.34 |
Profit margin | 12.311 |
EBITDA | 85M 1.6B |
Recommendations | Buy |
---|---|
12 Months Forecast | +42.4% upside |
Dividend yield Sector Avg | 1.34% 2.45% |
---|---|
Next Earnings | 7 sie 2025 |
Market Cap | 33B 98B |
---|---|
Previous open | 115.66 |
Previous close | 114.45 |
By Acuity
30%
70%
80 / 382 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
121.15 / 123.55 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
15 maj 2025, 08:36 UTC
Merck KGaA Shares Plunge After Outlook Cut on Tariff, Currency Risks
DJ
Read
15 maj 2025, 05:25 UTC
Merck KGaA Cuts Outlook Amid Macroeconomic Challenges
DJ
Read
28 kwi 2025, 11:25 UTC
Germany's Merck to Buy SpringWorks for $3.9 Billion -- Update
DJ
Read
28 kwi 2025, 06:41 UTC
Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal
DJ
Read
15 maj 2025, 08:21 UTC
Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks
DJ
Read
15 maj 2025, 06:53 UTC
Merck KGaA's Guidance Cut Should Cause Share-Price Pressure -- Market Talk
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA: Guidance Cut Reflects Impact of Current Macro-Economic, Geopolitical Environment
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q EBITDA EUR1.48B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Net Sales Between EUR20.9B and EUR22.4B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Now Sees 2025 EBITDA Before One-Time Items Between EUR5.8B and EUR6.4B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Had Seen 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Read
15 maj 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Adj EPS at EUR2.17
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Cuts 2025 View
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q After-Tax Profit EUR738M
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q Adj EPS EUR2.12
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q Sales EUR5.28B
DJ
Read
15 maj 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Ebitda Before One-Time Items EUR1.51B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q EBIT EUR1.01B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q Ebitda Before One-Time Items EUR1.535B
DJ
Read
15 maj 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Net Sales at EUR5.28B
DJ
Read
28 kwi 2025, 15:20 UTC
Merck KGaA's $3.9B SpringWorks Therapeutics Buy Underwhelms -- Market Talk
DJ
Read
28 kwi 2025, 09:20 UTC
Stocks to Watch Monday: DoorDash, Merck, Spirit AeroSystems, Airbus -- WSJ
DJ
Read
28 kwi 2025, 08:36 UTC
Germany's Merck's Deal to Acquire SpringWorks Makes Strategic Sense, but Price in Focus -- Market Talk
DJ
Read
28 kwi 2025, 06:06 UTC
Germany's Merck: Acquisition Will Strengthen Merck Healthcare Presence in U.S.
DJ
Read
28 kwi 2025, 06:05 UTC
Germany's Merck: Planned Acquisition Will Immediately Add Revenue, Accelerate Growth
DJ
Read
28 kwi 2025, 06:05 UTC
Germany's Merck: Deal Is for Purchase Price of $47 a Share in Cash
DJ
Read
28 kwi 2025, 06:04 UTC
Germany's Merck to Buy SpringWorks for About $3.9B
DJ
Read
28 kwi 2025, 06:02 UTC
Germany's Merck to Buy SpringWorks Therapeutics
DJ
Read
24 kwi 2025, 22:51 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 164.33 EUR 42.4%
High 190 EUR
Low 107 EUR
Based on 10 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.
By TipRanks
Buy
10 ratings
8
Buy
1
Hold
1
Sell
Based on 10 analysts giving stock ratings to Merck KGaA - Dist in the past 3 months.
By Trading Central
Short Term
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Neutral Evidence
The bullish and bearish events are balanced.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$